Evidence map›Paper›PMID 37642865›Full record

ArticleJournal of autism and developmental disorders2025

Prevalence and Characteristics of Adolescents with Autism Spectrum Disorder in the New York-New Jersey Metropolitan Area.

Walter Zahorodny, Josephine Shenouda, Kate Sidwell, Michael G Verile, Cindy Cruz Alvarez, Arline Fusco, Audrey Mars, Mildred Waale, Tara Gleeson, Gail Burack and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of autism and developmental disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Unlocking autism's complexity: theFrontiers in integrative neuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Walter ZahorodnyRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA. zahorodn@njms.rutgers.edu.ORCID http://orcid.org/0000-0001-9050-8796
Josephine ShenoudaRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Kate SidwellRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Michael G VerileRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Cindy Cruz AlvarezRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Arline FuscoRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Audrey MarsHunterdon Health, Flemington, NJ, USA.
Mildred WaaleRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Tara GleesonAtlantic Health System, Goryeb Children's Hospital, Morristown, NJ, USA.
Gail BurackRutgers University - Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Paul ZumoffRutgers University - New Jersey Medical School, 185 South Orange Ave, F-511, Newark, NJ, 07103, USA.
Rutgers, The State University of New Jersey · USGoryeb Children's Hospital · USHunterdon Medical Center · US

Funding

Governor's Council for Medical Research and Treatment of Autism CAUT17APL013
6 · The paper itself

Abstract

purposeAlmost all epidemiologic studies estimating autism spectrum disorder (ASD) prevalence have focused on school-age children. This study provides the first population-based data on the prevalence and expression of ASD among adolescents in a large US metropolitan region.

methodsActive multiple source ASD surveillance of adolescents aged 16-years was conducted according to the Autism and Developmental Disabilities Monitoring (ADDM) Network method in a four-county New Jersey metropolitan region. Prevalence estimates are provided, characteristics are described and comparison of the distribution and characteristics of ASD is offered for this cohort, at 8 and 16-years.

resultsASD prevalence was 17.7 per 1000 (95% CI: 16.3-19.2)]. One-in-55 males and one in 172 females were identified with ASD. High-SES was positively associated with ASD and White adolescents had higher ASD prevalence (22.2 per 1000) than Hispanic adolescents (13.1 per 1000). One in four study-confirmed individuals with ASD did not have an ASD diagnosis. A majority of ASD adolescents (58.8%) had a co-occurring neuropsychiatric disorder. White and High-SES individuals had greater likelihood of co-occurring disorder. The demographic distribution and functional profile of ASD was similar in this cohort at 8 and 16-years.

conclusionApproximately one-in-55 adolescents in our area had ASD, in 2014, and one-in-4 16-year-olds with ASD was not diagnosed. A majority (3-in-5) of the adolescents with ASD had a co-occurring neuropsychiatric disorder. ASD under-identification and the high frequency of co-disorders in adolescents with ASD pose significant challenges to care and support.

Indexed as

Autism Spectrum DisorderAdolescentChildComorbidityFemaleHumansMaleNew JerseyPrevalenceAdolescentsAutismPrevalencePublic health

Identifiers

PMID37642865
PMCPMC12069468
OpenAlexW4386253615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.